Company Profile
Citius Pharma Stock Price, News & Analysis
- Ticker:
- CTXR
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.64 USD (-17.79%)
Close
Last updated: August 6, 2026
16.6M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, CTXR closed down 17.8% at $0.6420. No new same-company headline was identified in the current news window.
Company overview
Business overview
Citius Pharma is a specialty pharmaceutical company focused on anti-infective, oncology-supportive, and hospital-related products. Its story is centered on commercializing a small number of highly specific healthcare assets.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Citius sits in specialty biopharma.
Business Model Characteristics
The business depends on product development, regulatory steps, and the ability to create commercial value from focused assets.
Position Within the Biotechnology Landscape
Citius is a small-cap specialty-pharma name whose stock is driven by launch and regulatory milestones.
Future catalysts
Citius’s catalysts are LYMPHIR and Mino-Lok-related updates, with the market watching whether the company can finally turn its infection-control story into something more durable. The next event that matters is the one that confirms the company still has a viable commercial path.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Citius Pharma (CTXR)?
Citius Pharma (CTXR) most recently closed at 0.64 USD, a -17.79% move versus the previous session.
What is the market cap of Citius Pharma (CTXR)?
Citius Pharma currently has a market capitalization of 16.6M USD on BioPharmSignal.
What does Citius Pharma do?
Citius Pharma is a specialty pharmaceutical company focused on anti-infective, oncology-supportive, and hospital-related products. Its story is centered on commercializing a small number of highly specific healthcare assets.
On which exchange is CTXR stock listed?
Citius Pharma (CTXR) is associated with NASDAQ, United States, Biopharma.
What is Citius?
Citius’s catalysts are LYMPHIR and Mino-Lok-related updates, with the market watching whether the company can finally turn its infection-control story into something more durable.
Which conditions is Citius Pharma targeting with Citius?
Citius Pharma is associated with oncology based on its company overview and current catalyst commentary.
How does Citius Pharma describe recent progress with Citius?
Citius’s catalysts are LYMPHIR and Mino-Lok-related updates, with the market watching whether the company can finally turn its infection-control story into something more durable.
What is Pharma?
Citius Pharma is a specialty pharmaceutical company focused on anti-infective, oncology-supportive, and hospital-related products.